Bicara Therapeutics Financial Ratios for Analysis 2023-2025 | BCAX

Fifteen years of historical annual and quarterly financial ratios and margins for Bicara Therapeutics (BCAX).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20242023
27.9315.32
--
--
--
--
--
--
--
--
--
--
--
--
-13.8234.94
-13.8234.94
-13.33-22.22
-13.8234.94
9.04-2,323.14
-4.45-78.65
-4.45-79.66

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-12-312024-09-302023-12-312023-09-30
-36.01--
----
----
----
----
----
----
----
----
----
----
----
----
--3.43--
--3.43--
--3.34--
--3.43--
-9.37--
0.00-4.100.00-62.91
--4.10--63.16